Vaxcyte, Inc. (PCVX) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Vaxcyte, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.655 -- 00:00:03.898 Good afternoon. My name is Jess, and I will be your conference operator today. 00:00:03.898 -- 00:00:08.984 At this time, I would like to welcome everyone to the Backsite fourth quarter and full 00:00:08.984 -- 00:00:12.528 year 2024 financial results conference call. 00:00:12.528 -- 00:00:15.991 All lines have been placed on mute to prevent any background noise. 00:00:15.991 -- 00:00:19.255 After the speaker's remarks, there will be a question and answer period. 00:00:19.255 -- 00:00:23.179 If you would like to ask a question during this time, simply press star followed by the 00:00:23.179 -- 00:00:27.884 number one on your telephone keypad. If you would like to withdraw your question, press 00:00:27.884 -- 00:00:33.084 star two. Today's call is being recorded. I would now like to turn the call over 00:00:33.084 -- 00:00:37.570 to Andrew Guggenheim, President and Chief Financial Officer of VacSight. 00:00:37.570 -- 00:00:39.533 Please go ahead, sir. 00:00:39.533 -- 00:00:43.078 Andrew Guggenheim Thank you, operator, and good afternoon, everyone. 00:00:43.078 -- 00:00:48.226 I'd like to welcome you to VacSight's earnings conference call to discuss our 2024 results 00:00:48.226 -- 00:00:50.910 and to provide a business update. 00:00:50.910 -- 00:00:55.757 I am joined today by our Chief Executive Officer, Grant Pickering, and our Executive 00:00:55.757 -- 00:00:59.870 Vice President and Chief Operating Officer, Jim Wassel. 00:00:59.870 -- 00:01:04.365 Earlier this afternoon, we issued a news release announcing our results. 00:01:04.365 -- 00:01:09.441 Copies of this and our other news releases, latest corporate presentation, and SEC 00:01:09.441 -- 00:01:14.972 filings can be found in the Investors in Media section of our website. 00...